TY - JOUR
T1 - Nociceptin produces antinociception after spinal administration in amphibians
AU - Stevens, Craig W.
AU - Martin, Kristin K.
AU - Stahlheber, Brad W.
N1 - Funding Information:
Supported in part by a research grant from the U.S. National Institutes of Health, NIDA 012448 (CWS) and a summer medical student scholarship from the Auxiliary to the Oklahoma Osteopathic Association (BWS). This paper is dedicated to the memory of Peace Corps Nepal volunteer, Phil Cyr, who was killed in the line of duty.
PY - 2009/1
Y1 - 2009/1
N2 - Nociceptin, also known as orphanin FQ, is a opioid-like neuropeptide that mediates its effects at the nociceptin receptor, a member of the G protein-coupled receptor superfamily. In mammals, nociceptin produces analgesia after spinal administration, however the role of nociceptin and nociceptin receptors in the modulation of noxious stimuli in non-mammalian species has not been examined. In an amphibian pain model using the acetic acid test with Rana pipiens, nociceptin and nociceptin1-13 amide produced dose-dependent antinociception (1-100 nmol), blocked by the nociceptin antagonist, [Nphe1]-nociceptin1-13 amide (30 nmol), but not the opioid antagonist, naltrexone (100 nmol/g, s.c.). Conversely, the antinociceptive effects of mu, delta, and kappa opioid receptor agonists were not blocked by the nociceptin antagonist. Nociceptin and nociceptin1-13 amide were the least potent of the opioid agonists tested. These studies demonstrate that spinal nociceptin receptors and not opioid receptors mediate the antinociceptive effect of nociceptin. Considered with previous findings, these behavioral data supports a role for nociceptin inhibition of spinal nociception in amphibians and perhaps all vertebrates.
AB - Nociceptin, also known as orphanin FQ, is a opioid-like neuropeptide that mediates its effects at the nociceptin receptor, a member of the G protein-coupled receptor superfamily. In mammals, nociceptin produces analgesia after spinal administration, however the role of nociceptin and nociceptin receptors in the modulation of noxious stimuli in non-mammalian species has not been examined. In an amphibian pain model using the acetic acid test with Rana pipiens, nociceptin and nociceptin1-13 amide produced dose-dependent antinociception (1-100 nmol), blocked by the nociceptin antagonist, [Nphe1]-nociceptin1-13 amide (30 nmol), but not the opioid antagonist, naltrexone (100 nmol/g, s.c.). Conversely, the antinociceptive effects of mu, delta, and kappa opioid receptor agonists were not blocked by the nociceptin antagonist. Nociceptin and nociceptin1-13 amide were the least potent of the opioid agonists tested. These studies demonstrate that spinal nociceptin receptors and not opioid receptors mediate the antinociceptive effect of nociceptin. Considered with previous findings, these behavioral data supports a role for nociceptin inhibition of spinal nociception in amphibians and perhaps all vertebrates.
KW - Amphibian
KW - Antinociception
KW - Nociceptin
KW - Nociceptin receptor
KW - Opioid receptor
UR - http://www.scopus.com/inward/record.url?scp=57449096550&partnerID=8YFLogxK
U2 - 10.1016/j.pbb.2008.08.022
DO - 10.1016/j.pbb.2008.08.022
M3 - Article
C2 - 18804120
AN - SCOPUS:57449096550
SN - 0091-3057
VL - 91
SP - 436
EP - 440
JO - Pharmacology Biochemistry and Behavior
JF - Pharmacology Biochemistry and Behavior
IS - 3
ER -